Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jyothy Labs Limited (JYOTHYLAB.NS)
Mumbai, IN
Jyothy Labs Limited, along with its affiliated companies, is a prominent manufacturer and marketer of diverse consumer products. Operating both domestically within India and in international markets, the company specializes in categories such as fabric care, dishwashing solutions, personal hygiene products, and household insecticides. Its operations are strategically divided into several key segments: The Dishwashing segment provides a comprehensive range of products including dish wash bars, liquids, powders, and even scrubbers (including steel variants) under popular brands like Pril and Exo. Through its Fabric Care segment, the company offers an array of items such as fabric whiteners, enhancers, detergent powders, and bar soaps, marketed under well-known names like Henko, Mr. White, Ujala, and More light. The Household Insecticides division focuses on pest control and air care, featuring mosquito repellent coils, liquids, and cards, as well as general insect repellents. These are distributed under brands including Maya, T- Shine, and Maxo. Its Personal Care segment boasts a wide portfolio encompassing body soaps, face washes, toothpastes, deodorants, talcum powders, aftershave products, hand sanitizers, and moisturizers, with brands such as Margo, Fa, and Neem Active. Specialized dry cleaning and laundry services are offered through the Laundry Services segment. Finally, the 'Others' segment covers products like incense sticks, toilet cleaners, vegetable cleaners, and floor polishers, primarily under the Joy of Shine brand. Founded in Mumbai, India, in 1983, the company initially operated as Jyothy Laboratories Limited before officially adopting the name Jyothy Labs Limited in July 2019.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.34% | -13.90% | +1.99% | -8.58% | -27.93% | -21.00% | -33.58% | +6.41% | +50.88% | +39.26% | +462.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 6 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+2.7% Q1'26: +4.2% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-10.1% Q1'26: -11.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+9.4% Q1'26: +22.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+13.2% ★ Q1'26: +11.3% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+34.8% ★ Q1'26: +27.8% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.11× ★ Q1'26: 0.13× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 12 Rev. Ana. 11 EPS Ana. |
Mar 2027 11 Rev. Ana. 10 EPS Ana. |
Mar 2028 12 Rev. Ana. 12 EPS Ana. |
Mar 2029 11 Rev. Ana. 10 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.98B
est: 5.60B (+6.8%)
|
6.19B
est: 6.95B (-10.9%)
|
9.11B
est: 10.67B (-14.6%)
|
11.04B
est: 12.08B (-8.6%)
|
13.19B
est: 13.42B (-1.7%)
|
15.06B
est: 15.33B (-1.8%)
|
16.00B
est: 16.35B (-2.2%)
|
16.85B
est: 17.56B (-4.0%)
|
16.73B
est: 17.42B (-4.0%)
|
18.14B
est: 18.88B (-3.9%)
|
17.11B
est: 18.17B (-5.8%)
|
19.10B
est: 19.33B (-1.2%)
|
21.97B
est: 22.00B (-0.1%)
|
24.86B
est: 24.82B (+0.2%)
|
27.61B
est: 27.78B (-0.6%)
|
28.68B
est: 28.87B (-0.6%)
|
29.39B
29.22B – 29.52B
+1.8% YoY
|
32.58B
32.06B – 33.36B
+10.8% YoY
|
35.05B
34.13B – 36.08B
+7.6% YoY
|
37.38B
36.58B – 38.38B
+6.6% YoY
|
| EBITDA |
1.09B
est: 831.66M (+31.2%)
|
961.93M
est: 1.44B (-33.0%)
|
1.07B
est: 1.51B (-29.3%)
|
1.31B
est: 984.85M (+32.7%)
|
1.54B
est: -316.15M (+586.2%)
|
1.60B
est: 711.91M (+124.8%)
|
2.23B
est: 1.65B (+35.3%)
|
2.55B
est: 1.41B (+81.3%)
|
2.70B
est: 1.67B (+61.5%)
|
2.99B
est: 2.61B (+14.4%)
|
2.46B
est: 2.45B (+0.4%)
|
3.09B
est: 2.09B (+47.7%)
|
2.39B
est: 2.25B (+6.4%)
|
3.08B
est: 2.49B (+23.8%)
|
4.74B
est: 2.74B (+72.8%)
|
5.05B
est: 6.33B (-20.2%)
|
6.43B
6.39B – 6.46B
+1.7% YoY
|
7.13B
7.02B – 7.30B
+10.8% YoY
|
7.67B
7.47B – 7.90B
+7.6% YoY
|
8.18B
8.01B – 8.40B
+6.6% YoY
|
| EBIT |
972.45M
est: 755.48M (+28.7%)
|
831.62M
est: 988.83M (-15.9%)
|
786.12M
est: 923.68M (-14.9%)
|
1.09B
est: 676.02M (+60.8%)
|
1.30B
est: 717.35M (+81.1%)
|
1.28B
est: 1.49B (-14.0%)
|
1.92B
est: 1.39B (+37.9%)
|
2.26B
est: 2.07B (+9.2%)
|
2.40B
est: 2.25B (+6.6%)
|
2.69B
est: 2.41B (+11.9%)
|
2.13B
est: 2.41B (-11.3%)
|
2.74B
est: 1.94B (+40.9%)
|
2.01B
est: 2.09B (-3.6%)
|
2.79B
est: 2.31B (+20.5%)
|
4.46B
est: 2.55B (+75.0%)
|
4.75B
est: 5.67B (-16.1%)
|
5.76B
5.72B – 5.78B
+1.7% YoY
|
6.38B
6.28B – 6.54B
+10.8% YoY
|
6.87B
6.69B – 7.07B
+7.6% YoY
|
7.32B
7.17B – 7.52B
+6.6% YoY
|
| Net Income |
743.41M
est: 957.85M (-22.4%)
|
657.37M
est: 921.83M (-28.7%)
|
445.82M
est: 1.06B (-57.8%)
|
196.48M
est: 491.05M (-60.0%)
|
814.32M
est: 217.65M (+274.1%)
|
1.21B
est: 938.90M (+29.0%)
|
780.77M
est: 1.30B (-39.9%)
|
2.08B
est: 840.75M (+147.5%)
|
1.86B
est: 2.08B (-10.4%)
|
2.05B
est: 1.98B (+3.7%)
|
1.70B
est: 1.97B (-13.4%)
|
1.99B
est: 1.70B (+17.3%)
|
1.62B
est: 1.83B (-11.5%)
|
2.40B
est: 2.03B (+18.2%)
|
3.69B
est: 2.23B (+65.6%)
|
3.70B
est: 3.86B (-4.0%)
|
3.56B
3.50B – 3.62B
-7.7% YoY
|
3.71B
3.35B – 4.10B
+4.2% YoY
|
4.25B
3.56B – 4.92B
+14.5% YoY
|
4.54B
4.41B – 4.69B
+6.8% YoY
|
| SGA |
—
est: 1.06B (-100.0%)
|
21.99M
est: 1.43B (-98.5%)
|
1.30B
est: 2.14B (-39.2%)
|
3.31B
est: 2.05B (+61.3%)
|
4.07B
est: 4.00B (+1.7%)
|
3.79B
est: 4.93B (-23.2%)
|
3.20B
est: 3.68B (-12.9%)
|
3.16B
est: 5.17B (-38.9%)
|
3.18B
est: 4.84B (-34.2%)
|
3.42B
est: 5.10B (-33.0%)
|
3.44B
est: 4.85B (-29.2%)
|
3.58B
est: 3.42B (+4.9%)
|
4.11B
est: 3.67B (+11.9%)
|
4.41B
est: 4.07B (+8.3%)
|
5.31B
est: 4.48B (+18.5%)
|
5.71B
est: 5.53B (+3.2%)
|
5.63B
5.59B – 5.65B
+1.7% YoY
|
6.24B
6.14B – 6.38B
+10.8% YoY
|
6.71B
6.53B – 6.91B
+7.6% YoY
|
7.15B
7.00B – 7.35B
+6.6% YoY
|
| EPS |
2.56
est: 2.61 (-1.8%)
|
2.22
est: 2.68 (-17.1%)
|
1.38
est: 1.46 (-5.8%)
|
0.59
est: 2.40 (-75.4%)
|
2.38
est: 3.45 (-31.1%)
|
3.35
est: 3.89 (-14.0%)
|
2.16
est: 4.43 (-51.2%)
|
5.74
est: 4.03 (+42.4%)
|
5.12
est: 4.58 (+11.8%)
|
5.62
est: 5.79 (-2.9%)
|
4.64
est: 5.77 (-19.7%)
|
5.43
est: 6.38 (-14.9%)
|
4.41
est: 5.33 (-17.3%)
|
6.53
est: 6.66 (-1.9%)
|
10.06
est: 10.49 (-4.1%)
|
10.09
est: 10.50 (-3.9%)
|
9.69
9.54 – 9.84
-7.7% YoY
|
10.10
9.11 – 11.17
+4.2% YoY
|
11.57
9.69 – 13.40
+14.5% YoY
|
12.35
12.01 – 12.78
+6.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 909.0K | 0.06% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 64.7K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 28.7K | 0.48% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 3.20M | 0.06% |
| 5 | Vanguard ESG International Stock ETF VSGX | 0.00% | 76.4K | 0.10% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.00% | 3.56M | 0.05% |
| 7 | Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating V3AA.L | 0.00% | 8.7K | 0.24% |
| 8 | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing V3AL.L | 0.00% | 8.7K | 0.24% |
| 9 | Vanguard Total World Stock ETF VT | 0.00% | 268.3K | 0.06% |
| 10 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 5.1K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Moothedath Ramachandran Jyothy | MD & Chairman of the Board | 44M | female |
| Moothedath Panjan Ramachandran | Founder & Chairman Emeritus | 36M | male |
| T. Ananth Rao | Whole Time Director and Director of Operations & Commercial | 35M | male |
| Ravi Razdan | Whole Time Director and Director of IT & HR | 22M | male |
| Pawan Kumar Agarwal | Chief Financial Officer | — | male |
| Shreyas Parag Trivedi | Head of Legal, Compliance Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for JYOTHYLAB.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
